Skip to main content

MARSHALL WACE, LLP

Position in ALKS — Alkermes plc.

CIK 1318757 LONDON, X0

Position in ALKS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$50,825,589
+$15,489,565 QoQ
Shares Held
969,954
-2.9% QoQ
Ownership
0.578%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#41
of 421 holders
Holding Since
Mar 2020
11 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in ALKS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $609,159,561 across 30 Drug Manufacturers - Specialty & Generic names. ALKS ranks #4 (8.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 ALKS
Alkermes plc.
This page
969,954 $50,825,589

All Filings in ALKS

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $50,825,589 969,954
2026-03-31 $35,336,024 999,322
2025-12-31 $3,634,573 129,899
2025-06-30 $5,936,889 207,511
2023-09-30 $49,522,071 1,768,014
2023-06-30 $22,694,910 725,077
2023-03-31 $3,196,858 113,404
2022-12-31 $2,963,246 113,404
2021-09-30 $648,966 21,043
2020-12-31 $955,425 47,891
2020-03-31 $274,888 19,063